"Triazoles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
Descriptor ID |
D014230
|
MeSH Number(s) |
D03.383.129.799
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Triazoles".
Below are MeSH descriptors whose meaning is more specific than "Triazoles".
This graph shows the total number of publications written about "Triazoles" by people in this website by year, and whether "Triazoles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2002 | 2 | 1 | 3 |
2004 | 2 | 0 | 2 |
2005 | 2 | 1 | 3 |
2007 | 2 | 0 | 2 |
2009 | 2 | 0 | 2 |
2010 | 4 | 2 | 6 |
2011 | 3 | 1 | 4 |
2013 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2015 | 0 | 2 | 2 |
2016 | 2 | 0 | 2 |
2017 | 0 | 2 | 2 |
2018 | 2 | 0 | 2 |
2020 | 2 | 1 | 3 |
2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Triazoles" by people in Profiles.
-
Telescoped Oxidation and Cycloaddition of Urazoles to Access Diazacyclobutenes. J Org Chem. 2022 06 03; 87(11):7494-7500.
-
Targeting HIF-a for robust prevascularization of human cardiac organoids. J Tissue Eng Regen Med. 2021 02; 15(2):189-202.
-
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. Am J Hematol. 2021 01; 96(1):E5-E8.
-
Biased Opioid Receptor Ligands: Gain without Pain. Trends Endocrinol Metab. 2020 11; 31(11):801-802.
-
Substituted diphenylamine antioxidants and benzotriazole UV stabilizers in blood plasma of fish, turtles, birds and dolphins from North America. Sci Total Environ. 2019 Jan 10; 647:182-190.
-
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas. J Clin Oncol. 2018 06 10; 36(17):1702-1709.
-
Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4. Nat Med. 2017 Sep; 23(9):1063-1071.
-
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol. 2017 Apr 01; 35(10):1061-1069.
-
Posaconazole Substitution for Voriconazole-Associated Phototoxic Effects. JAMA Dermatol. 2016 07 01; 152(7):839-41.
-
The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma. Mol Cancer Ther. 2016 05; 15(5):1018-28.